ARFLEYDA

Pharmaceutical preparations for the treatment of familial Mediterranean fever; Pharmaceutical preparations for the treatment of adult-onset Still's disease; Pharmaceutical preparations for the treatment of idiopathic recurrent pericarditis; Pharmaceutical preparations for the treatment of recurrent pericarditis; Pharmaceutical preparations for secondary prevention of major adverse cardiovascular events after ST-elevation myocardial infarction; Pharmaceutical preparations for the treatment of chronic heart failure; Pharmaceutical preparations for the treatment of macrophage activation syndrome; Pharmaceutical preparations for the treatment of systemic juvenile idiopathic arthritis; Pharmaceutical preparations for the treatment of cryopyrin-associated periodic syndromes; Pharmaceutical preparations for the treatment of tumor necrosis factor receptor associated periodic syndrome; Pharmaceutical preparations for the treatment of Schnitzler syndrome; Pharmaceutical preparations for the treatment of acute gout attacks